About Caspase-8
Caspase-8 (CASP8) is a protein
from Homo sapiens identified by UniProt accession
Q14790, 479 residues long.
MolForge cross-references it against 0 known binders and
835 disease associations.
Target properties
| Protein name | Caspase-8 |
| UniProt accession | Q14790 |
| Gene | CASP8 |
| Organism | Homo sapiens |
| Length | 479 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (835)
Diseases linked to this target (Open Targets).
- Autoimmune lymphoproliferative syndrome with recurrent viral infections · score 0.74
- autoimmune lymphoproliferative syndrome type 2B · score 0.73
- head and neck squamous cell carcinoma · score 0.64
- neurodegenerative disease · score 0.54
- viral disease · score 0.51
- breast adenocarcinoma · score 0.48
- cervical squamous cell carcinoma · score 0.43
- hepatocellular carcinoma · score 0.42
- cutaneous squamous cell carcinoma · score 0.41
- nasopharyngeal neoplasm · score 0.41
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14790-F1 | alphafold | PREDICTED | 81.87 | — |
Amino-acid sequence (479 residues)
MDFSRNLYDI GEQLDSEDLA SLKFLSLDYI PQRKQEPIKD ALMLFQRLQE KRMLEESNLS FLKELLFRIN RLDLLITYLN TRKEEMEREL QTPGRAQISA YRVMLYQISE EVSRSELRSF KFLLQEEISK CKLDDDMNLL DIFIEMEKRV ILGEGKLDIL KRVCAQINKS LLKIINDYEE FSKERSSSLE GSPDEFSNGE ELCGVMTISD SPREQDSESQ TLDKVYQMKS KPRGYCLIIN NHNFAKAREK VPKLHSIRDR NGTHLDAGAL TTTFEELHFE IKPHDDCTVE QIYEILKIYQ LMDHSNMDCF ICCILSHGDK GIIYGTDGQE APIYELTSQF TGLKCPSLAG KPKVFFIQAC QGDNYQKGIP VETDSEEQPY LEMDLSSPQT RYIPDEADFL LGMATVNNCV SYRNPAEGTW YIQSLCQSLR ERCPRGDDIL TILTEVNYEV SNKDDKKNMG KQMPQPTFTL RKKLVFPSD
Explore Caspase-8 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets